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Objective: The purpose of this study was to examine a range of
cognitive measures as candidate phenotypic liability markers for
psychosis in a uniquely large sample of patients with psychosis, their
unaﬀected relatives and control subjects.
Method: Patients with non-aﬀective psychosis (n = 1093), their
unaﬀected siblings (n = 1044), parents (n = 911), and controls
(n = 587) completed a comprehensive cognitive test battery. Cognitive
functioning was compared using tests of verbal learning and memory,
attention ⁄vigilance, working memory, processing speed, reasoning and
problem solving, acquired knowledge, and social cognition. Age- and
gender-adjusted z-scores were compared between groups using mixed-
model analyses of covariance. Clinically relevant impairment ()1a n d
)2 SD from control mean) was compared between subject groups.
Results: Patients performed signiﬁcantly worse than controls in all
cognitive domains (z-range )0.26 to )1.34). Siblings and parents
showed alterations for immediate verbal learning, processing speed,
reasoning and problem solving, acquired knowledge, and working
memory (z-range )0.22 to )0.98). Parents showed additional
alterations for social cognition. Prevalence of clinically relevant
impairment in relatives ranged from 50% ()1 SD criterion) to 10%
()2 SD criterion).
Conclusion: Cognitive functioning is a candidate intermediate
phenotype given signiﬁcant small to large alterations in patients and
intermediate alterations in ﬁrst-degree relatives.
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Significant outcomes
• Patients with non-affective psychotic disorder are characterized by cognitive alterations across all
cognitive domains with small effect sizes compared with meta-analytic results.
• Verbal learning, processing speed, reasoning and problem solving, working memory, and acquired
knowledge are the most promising cognitive intermediate phenotypes, demonstrating alterations in
genetic high-risk groups.
• The distribution of clinically relevant impairments in patients and their ﬁrst-degree relatives suggests
a continuum of neuropsychological functioning, with approximately 30% of the patients and 50% of
the relatives displaying no clinically manifest ()1 SD) deﬁcit.
Limitations
• Effect sizes in parents may have been inﬂated because of differences in age range between the parent
and control group.
• Not all subjects had complete cognitive test scores, which may have impacted on the effect sizes.
• Group differences in educational achievement and IQ remain a potential explanation for group
differences in other cognitive test scores that cannot be ruled out through statistical adjustment.
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Cognitive alteration is a stable, trait-related aspect
of schizophrenia that has been associated with
impaired quality of life and poorer functional
outcome (1). Subtle cognitive deﬁcits are present
before psychosis onset and may help to predict
conversion to psychosis in clinical high-risk sub-
jects who are in the putative prodromal phase of
psychosis (2, 3). Attenuated cognitive alterations
have also been reported in clinically unaﬀected
relatives of schizophrenia patients; these relatives
are referred to as being at genetic high risk for
psychosis. Cognitive alterations may therefore
reﬂect the expression of genetic vulnerability to
schizophrenia (4–7). Identifying such cognitive
intermediate phenotypes may be a productive
approach in genetic linkage and association studies
in schizophrenia, as they are closer to the mech-
anism for gene action than the overall disease
phenotype.
Although evidence on cognitive alterations as
intermediate phenotypes of schizophrenia is
promising, sample sizes have been limited (8).
This is illustrated by the fact that the most recent
literature review of studies on the young relatives
of psychotic patients included 18 studies with a
mean of 102 high-risk relatives (range 29–322)
and 84 control subjects (range 26–201), while only
ﬁve studies included a patient group (mean 76,
range 27–207) (4). Thus, the most appealing
evidence to date originates from meta-analyses
and reviews. Summarizing evidence related to a
speciﬁc hypothesis can be distorted, however, by
the selective publication of studies with certain
(especially positive) results (9). In addition, studies
on cognition in genetic high-risk samples have
been limited by i) the analysis of diﬀerent
biological relatives as one group (siblings, children
and parents), ii) the inappropriate screening for
psychiatric disorders in the relatives, and iii)
limited assessment of cognitive functions (8). In
combination with a high within- and between-
subject variability of cognitive performance in
genetic high-risk samples (8), these methodo-
logical limitations may have hampered the iden-
tiﬁcation of cognitive intermediate phenotypes.
There is also a lack of knowledge about the
proportion of unaﬀected relatives who display
clinically relevant cognitive impairment and what
percentage is cognitively spared. While previous
studies have estimated the proportion of cogni-
tively spared patients at around 15–30% (8, 10),
little is known about this percentage in genetic
high-risk subjects.
Aims of the study
The aim of the present study was to test a broad
range of cognitive measures as candidate interme-
diate phenotypes in a large population of patients
with a non-aﬀective psychotic disorder, their unaf-
fected siblings and parents, and control subjects.
Therefore, age- and gender-adjusted z-scores were
compared between subject groups. Second, the
proportions of clinically relevant cognitive impair-
ment (no, mild, moderate, severe) were compared
between subject groups, using both 1 and 2 SD
below the control mean as impairment cut-oﬀ.
Material and methods
The sample of the Genetic Risk and Outcome of
Psychosis study (GROUP) was described previ-
ously (11). The baseline GROUP sample consists
of 1120 patients with a non-aﬀective psychotic
disorder, 1057 unaﬀected siblings, 919 parents, and
590 unrelated control subjects.
Within the patient group, 84% had a schizo-
phrenia-related disorder (DSM-IV-TR code 295.x,
80% schizophrenia, 13% schizo-aﬀective disorder,
7% schizophreniform disorder; n = 945), 1% were
diagnosed with psychotic illness in the context of
substance abuse or somatic illness (DSM-IV-TR
code 293.x ⁄292.x, n = 9), and 13% fulﬁlled crite-
ria for other psychotic disorders (DSM-IV-TR
code 297 ⁄298, n = 149). Six patients had a missing
diagnosis but fulﬁlled inclusion criteria, and 11
patients had a ﬁnal diagnosis of aﬀective psychosis
after fulﬁlling diagnostic criteria of non-aﬀective
psychosis at study entry, which may have been the
result of subtle diagnostic changes between the
time of identiﬁcation for inclusion and actual
assessment.
The mean age at onset of psychosis was
22.6 ± 6.7 years (range 10–54), and the mean
illness duration was 4.4 ± 4.1 years (range 0.1–
41.1). At the time of testing, 86.1% of the patients
were on antipsychotic treatment with one or more
antipsychotics; the most frequently used antipsy-
chotics were olanzapine (27.8%), risperidon
(23.7%), and clozapine (11.6%). The mean
number of psychotic episodes was 1.7 ± 1.1
(range 1–8), and the mean number of psychiatric
hospitalizations was 1.9 ± 2.3 (range 0–30).
According to Positive and Negative Syndrome
Scale (PANSS) remission criteria (12, 13), 45.1%
of the patients were in remission from psychosis at
the time of testing. Patients had a mean PANSS
positivescoreof14.0 ± 6.4(range7–41)andamean
PANSS negative score of 15.0 ± 6.6 (range 7–39).
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mental disorder in 12.1% of the siblings (n = 152),
19.4% of the parents (n = 178), and 10.0% of the
controls (n = 59). Depressive disorders were by
far the most common, reported in 10.5% of
siblings (n = 111), 17.7% of parents (n = 163),
and 8.5% of controls (n = 50).
Verbal learning and memory was assessed with a
visually presented Word Learning Task (WLT;
14). Outcome measures were: immediate recall
(number of words recalled over the three 15-word
trials), retention rate (delayed free recall after
20 min divided by the maximum score of immedi-
ate recall trials 1–3), and recognition (true posi-
tives–false positives). Attention ⁄vigilance was
assessed using a Continuous Performance Test
(CPT-HQ) with working memory load, which is
known in the literature as CPT-AX (15). Out-
come measures were reaction time (reaction time
for correct detections) and accuracy (proportion
of correct detections). The Response Shifting
Task (RST), a modiﬁed version of the Competing
Programs Task (16, 17), was administered to assess
set-shifting ability from an imitation response rule
to a reversal response rule. Outcome variables were
accuracy cost (proportion correct in the imitation
condition–proportion correct in the reversal con-
dition), and reaction time cost (reaction time in the
reversal condition–reaction time in the imitation
condition). The ﬁrst response in each block and the
responses that were preceded by errors were
excluded from analyses (18). In addition, only
reaction times for correct responses were used, and
trials with a reaction time shorter than 150 ms
were eliminated from the analyses. The WAIS-III
(19) subtest Arithmetic was assessed to measure
working memory. This subtest is a relatively
complex measure of working memory capacity,
because it also addresses verbal comprehension
and arithmetic skills, both of which are associated
with educational level (20). The WAIS-III subtest
Digit Symbol-coding was used as a measure of
speed of processing. Reasoning and problem
solving was assessed using the subtest Block
Design from the WAIS-III. The WAIS-III
Information subtest was used as a measure of
acquired knowledge. The cognitive assessment
included two dimensions of social cognition. The
outcome measures of the Degraded Facial Aﬀect
Recognition task [DFAR; (21)] were the propor-
tion of correctly recognized neutral, happy, fearful
and angry faces and the overall proportion of
correct answers. The short form of the Benton
Facial Recognition Test (BFRT) (22) was assessed
to be used as a covariate to adjust for non-
emotional facial processing skills. Theory of mind
was assessed using the Hinting Task, which
assesses the mentalizing capacity required to com-
prehend real intentions behind indirect speech (23).
Outcome measure was the sum of the ten separate
item scores (range 0–20). It took approximately
90–120 mins to complete the neuropsychological
tests, which were administrated in the following
ﬁxed order: WLT immediate recall, RST, CPT-
HQ, Digit Symbol-coding, WLT delayed recall,
WLT recognition, DFAR, BFRT, Information,
Arithmetic, Block Design, Hinting Task.
Statistical analyses
The data were analyzed using the spss 17.0 (SPSS
Inc., Chicago, IL, USA) statistical package. To
facilitate the comparison of cognitive functioning
between patients, siblings, parents and control
subjects, raw scores were converted into z-scores.
Given that patients and siblings belong to diﬀerent
age categories than parents (Table 1), z-scores were
adjusted for age and gender by dividing the control
group into reference groups, setting the minimum
of 50 subjects per stratum. This resulted in the
following eight categories following methods
described by Keefe et al. (24):
Age £20: 71 males and 64 females
Age 21–30: 85 men and 105 women
Age 31–40: 59 men and 65 women
Age ‡41: 55 men and 85 women
Adjusted z-scores were computed as follows. Let
Xjk be the raw score X on subtest j (j = 1–15) for
subject k. Assume that subject k has sex l
Table 1. Socio-demographic characteristics of patients, siblings, parents and controls
Patients, n = 1093 Siblings, n = 1044 Parents, n = 911 Controls, n = 587
Between-group comparisons
Test statistic P-value
% Male gender 76.2 45.8 42.8 45.5 v
2 = 308.6 <0.001
Age (years) 27.7 € 8.1 27.8 € 8.3 54.8 € 6.9 30.4 € 10.6 F = 2354.1 <0.001
WAIS-III estimated IQ 94.9 € 16.1 102.6 € 15.5 103.1 € 17.0 109.6 € 15.2 F = 113.3 <0.001
Educational degree subject 4.1 € 2.0 5.1 € 2.1 5.1 € 2.3 5.4 € 1.8 F = 74.4 <0.001
Educational degree parent 5.2 € 2.4 5.2 € 2.4 3.4 € 2.3 5.0 € 2.4 F = 33.7 <0.001
Wechsler-Adult Intelligence Scale short form (54).
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m( 1£ 20, 2 = 21–30, 3 = 31–40, 4 ‡ 41 years).
The scaled score is then computed as follows:
zcorrected =( Xjk ) Mjlm) ⁄SDjlm; where Mjlm and
SDjlm are the mean and the SD, respectively, for
test j of the control population for sex l and age
category m. Resulting z-scores are identical to
Glasss delta estimator of eﬀect size (25). Observa-
tions with more than 3 SDs from the mean were
considered outliers and were replaced by the mean
plus or minus three times the SD.
Subsequently, adjusted z-scores were compared
between patients ⁄siblings ⁄parents and control
subjects. In addition, adjusted z-scores were com-
pared between siblings ⁄parents and patients. To
control for intra-family correlation, mixed-model
analyses of covariance (ancovas) were performed
in which family was used as a random factor with
a random intercept. Status (patient, sibling,
parent, control) was the independent variable.
Dependent variables were adjusted z-scores for 18
outcome measures derived from 10 cognitive tests.
Although educational level of the subject and IQ
may be associated with many of the putative
intermediate phenotypes in question, they are also
powerfully aﬀected by schizophrenia (26). There-
fore, the highest educational degree that had been
obtained by one of the parents was entered into
the model as a covariate instead. Because the
Dutch educational system already diﬀerentiates
after primary school, we chose a coding system
other than years of education. This ordinal eight-
point scale indicates the level of education and
ranges from primary school to university. Mixed-
model ancovas for the DFAR variables incorpo-
rated the BFRT test scores as an additional
covariate. Because mixed-model ancovas were
performed for multiple cognitive outcome param-
eters (n = 18), a Bonferroni correction was
adopted by setting the alpha level to 0.05 ⁄18 =
0.0028.
Between-group comparisons were subsequently
performed only in those cognitive parameters for
which the eﬀect of Status in the ancova was
signiﬁcant. Five post hoc analyses were performed
for each of those cognitive parameters, ﬁrst to
compare patients ⁄siblings ⁄parents with controls,
and then to compare siblings ⁄parents with
patients. For these post hoc analyses, the alpha
value was set at 0.05 ⁄(5 · the number of cognitive
parameters for which post hoc comparisons were
performed). The same correction for multiple
analyses was also applied to the much more
conservative alpha value of 0.001.
Normality of cognitive outcome measures was
visually inspected and conﬁrmed if the test statistic
W in the Shapiro–Wilk test exceeded 0.90. All but
three outcome measures were normally distributed.
Ceiling eﬀects were present for CPT accuracy,
WLT recognition, and the Hinting Task. Data
transformation did not improve the normality of
the distributions; therefore, both parametric and
non-parametric testing were conducted. Secondary
to the mixed-model ancovas, group comparisons
were performed using Kruskal–Wallis tests, which
were followed by post hoc Mann–Whitney tests
with Bonferroni correction. To minimize the risk of
type-I errors, the analyses that yielded the most
conservative results were chosen for further
discussion.
Raw test scores were then converted into
dichotomous variables of impaired or not
impaired. A priori, both 1 SD (27–29) and 2 SD
(30) below age- and gender-corrected control mean
were selected as the cut-oﬀ for clinical impairment.
For cognitive tests with more than one outcome
measure (e.g., RST reaction time and RST accu-
racy), an impairment was deemed present if the
score of at least one measure was below the cut-oﬀ.
Impairment scores were summed to generate total
impairment scores (range 0–10). Based on the
control mean of 1.8 tests with an impairment
(based on )1 SD cut-oﬀ), the criterion for not
impaired was deﬁned as 0–2 tests with an impair-
ment. For the width of the following categories, the
control SD of 1.5 was used, resulting in the
categories mild impairment (impairment on 3–4
tests), moderate impairment (impairment on 5–6
tests), or severe impairment (impairment on seven
or more tests). Total impairment scores were
calculated for subjects who had completed at
least nine out of 10 cognitive tests. Chi-square
tests were used to detect statistically signiﬁcant
diﬀerences in total impairment scores between the
subject groups. A Bonferroni correction was
applied by setting the alpha value to
0.05 ⁄16 = 0.003, because four dependent variables
were compared between four subject groups.
Analyses were performed using spss 17.0 for
Windows. Release 2.0 of the GROUP database
was used for the analyses.
Results
Data inspection
Although WLT recognition was assessed for
89.3% of the subjects, reliable data were available
for this task for only 47.7% of all subjects. This
was mainly because of technical problems. These
test scores were included in the mixed-model
ancovas, but not in the calculation of total
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of one missing value. Inspection of the missing
values for the remaining nine cognitive tests
showed that 2922 subjects (79.3%) had completed
all tests, while 453 individuals (12.3%) had missing
data for one test and 260 individuals (7.1%) had
missing data for more than three tests. For 49
individuals (1.3%), no cognitive test results were
obtained, so these subjects were excluded from the
analyses.
The mean proportion of missing tests was 6.0%
(range3.4–11.4%).Testdurationandtestrankwere
notassociatedwithproportionofmissings,buttasks
with computerized scoring had a higher mean
proportion of missings (9.9%) than the paper-
pencil scoring tasks (4.1%). When comparing
demographic variables of subjects categorized by
the number of tests missing (no missings, 1–3
missings, >3 missings, not tested), no signiﬁcant
diﬀerences were found for gender, highest educa-
tional degree, or age. Patient status, however, was
associated with the number of missing values. The
proportionofmissingsbetweenpatients(n = 1093)
and the other three subject groups taken together
(n = 2565)was12.5%vs.12.2%(1–3testsmissing),
9.5% vs. 6.0% (>3 tests missing), and 2.4% vs.
0.9% (not tested), v
2(3) = 28.27, P < 0.001.
Group comparisons
Patients were signiﬁcantly more often male com-
pared to siblings, parents, and controls. The mean
age of patients and siblings was lower than the
mean age in controls and in parents. Furthermore,
there were statistical diﬀerences between the four
subject groups in IQ, educational degree of the
subject, and educational degree of the parent
(Table 1).
Observed means and SD for cognitive test scores
and results from mixed-model ancovas are pre-
sented in Table 2. Because mixed-model ancovas
were signiﬁcant for 15 out of 18 cognitive outcome
measures, post hoc tests were denoted as signiﬁcant
at the 0.05 level if the P-value was smaller than
0.0007, resulting from 0.05 ⁄(5 · 15). Moreover,
post hoc tests were denoted as signiﬁcant at the
0.001 level if the P-value was smaller than 0.00001,
resulting from 0.001 ⁄(5 · 15). Age- and gender-
adjusted z-scores in patients, siblings, and parents
are displayed in Fig. 1. Because higher scores
reﬂected worse performance for CPT-HQ reaction
time, RST reaction time cost, and RST accu-
racy cost, z-scores for these measures were
inverted.
For the three non-normally distributed tests,
non-parametric testing yielded somewhat
diﬀerent results compared with the results from
mixed-model ancovas. Mann–Whitney testing
yielded signiﬁcantly worse performance on the
CPT accuracy in parents (median = 583.65) com-
pared with control subjects (median = 815.42),
U = 143156.50, Z = )10.71, P < 0.001, r =
)0.29. In addition, Mann–Whitney testing did
not yield signiﬁcant results on the WLT recogni-
tion for the comparison between patients (median
= 451.21) and parents (median = 499.78), U =
99099.00, Z = )2.72, Pr = 0.450, r = )0.09, or
for the comparison between siblings (median =
386.20) and control subjects (median = 442.00),
U = 66659.50, Z = )3.28, P = 0.075, r = 0.12.
For the Hinting Task, no diﬀerences emerged
between parametric and non-parametric testing.
For WLT recognition, the more conservative non-
parametric results were chosen over results from
mixed-model ancovas. For the other two tasks, the
parametric results were maintained.
Against the background of recent ﬁndings (31),
the analyses were repeated with cannabis use
(current, lifetime, or never) as an additional
covariate. Co-varying for cannabis, however, did
not change any of the group comparisons from
signiﬁcant to non-signiﬁcant or vice versa (results
not shown).
Total impairment scores
Figure 2a shows that with a cut-oﬀ of 1 SD below
control mean, 29.6% of patients are classiﬁed as
having no cognitive impairment against 71.4% of
controls, with in-between rates for parents and
siblings [v
2(3) = 214.4, P < 0.05]. While the pro-
portions of mild impairment did not diﬀer between
subjectgroups[v
2(3) = 10.4,P = 0.12],bothmod-
erate [v
2(3) = 86.3, P < 0.05] and severe impair-
ment [v
2(3) = 127.6, P < 0.05] showed signiﬁcant
diﬀerences between groups. Patients showed the
highest proportion of moderate and severe impair-
ment and control subjects the lowest, with in-betw-
een rates for parents and siblings. Figure 2b shows
that with a cut-oﬀ score of 2 SD, the rate of subjects
classiﬁed as having no impairment increased to
70.8% in patients and 98.2% in controls, with in-
between rates for parents and siblings
[v
2(3) = 225.3, P < 0.05]. Mild impairment rates
decreasedto18.5%inpatientsand1.3%incontrols,
v
2(3) = 114.3, P < 0.05. While 7.8% of patients
displayedmoderateimpairment,thepercentagewas
very low in the other three subject groups
[v
2(3) = 93.0, P<0.05]. Severe impairment was
rare in patients (2.9%), very rare in parents and
siblings(0.2%and0.3%,respectively),andabsentin
controls, v
2(3) = 46.8, P < 0.05.
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Cognitive functioning was analyzed in two ways in
this uniquely large sample of patients with psy-
chotic disorder, their unaﬀected relatives, and
control subjects. First, group comparisons revealed
that patients performed signiﬁcantly worse than
control subjects in all cognitive domains, while
unaﬀected relatives were outperformed by control
subjects in selected domains. Verbal learning and
memory, speed of processing, acquired knowledge,
working memory, and reasoning and problem
solving emerged from these analyses as candidate
intermediate phenotypes. Second, additional
analyses were conducted to explore how mean
group diﬀerences translated into proportions of
clinically relevant impairment. Based on the 1 SD
cut-oﬀ, around half of the unaﬀected relatives
displayed some level of cognitive impairment.
However, this proportion diminished to around
10% when adapting 2 SD as the cut-oﬀ for
impairment.
Patients displayed a generalized cognitive alter-
ation extending across most cognitive domains.
While patients scores were signiﬁcantly below
control mean on most cognitive outcome measures,
only WLT immediate recall, CPT accuracy, Digit
Symbol-coding, Arithmetic, and Hinting Task
performance would be classiﬁed as impaired
according to the traditional neuropsychological
criterion of )1 SD below the control mean (27–29).
This is in line with previous studies that reported
largest eﬀect sizes in the domains of attention,
speed of information processing, working memory,
Table 2. Observed means and SD of cognitive test scores and P-values of between-subject comparisons following mixed-model ancovas using z-standardized scores and
adjusting for parental education level
Outcome measure
Patients
(n = 1093)
M (SD)
Siblings
(n = 1044)
M (SD)
Parents
(n = 911)
M (SD)
Controls
(n = 587)
M (SD)
Test statistic (df)
P* value
Patients vs.
Controls
–
P* value
Siblings vs. Controls
Siblings vs. Patients
Parents vs. Controls
Parents vs. Patients
WLT immediate recall 22.93 (6.09) 26.89 (5.77) 23.26 (6.11) 28.43 (5.38) 132.17 (3, 3111)
P < 0.001
<0.001
–
<0.001
<0.001
<0.001
<0.001
WLT retention rate 0.77 (0.21) 0.84 (0.17) 0.78 (0.20) 0.83 (0.16) 13.22 (3, 3105)
P < 0.001
<0.001
–
NS
<0.001
NS
NS
WLT recognition 11.03 (3.48) 12.36 (2.99) 11.45 (3.33) 12.96 (2.13) 71.69 (3)
<0.001
<0.001
–
NS <0.001 <0.001 NS
RST reaction time cost 205.84 (221.40) 198.43 (208.91) 216.42 (240.00) 194.78 (176.21) 0.72 (3, 2610)
P = 0.54
–
–
–
–
–
–
RST accuracy cost 0.26 (0.27) 0.22 (0.25) 0.35 (0.33) 0.22 (0.25) 12.38 (3, 2841)
P < 0.001
<0.001
–
NS
<0.001
NS
NS
CPT reaction time 430.17 (84.43) 410.24 (78.39) 429.01 (81.90) 412.80 (82.67) 37.30 (3, 2856)
P < 0.001
<0.001
–
NS
<0.001
NS
<0.001
CPT accuracy 98.75 (2.27) 99.51 (1.50) 98.89 (2.18) 99.63 (1.01) 40.62 (3, 2831)
P < 0.001
<0.001
–
NS
<0.001
NS
<0.001
Digit Symbol-coding 65.43 (16.26) 79.23 (15.44) 67.97 (16.72) 83.89 (14.60) 223.40 (3, 3108)
P < 0.001
<0.001
–
<0.001
<0.001
<0.001
<0.001
Information 16.78 (5.46) 16.83 (5.20) 17.61 (5.43) 18.82 (4.65) 33.69 (3, 3050)
P < 0.001
<0.001
–
<0.001
<0.05
<0.001
<0.05
Arithmetic 12.28 (4.78) 13.84 (4.43) 13.70 (4.25) 15.30 (4.16) 122.57 (3, 3110)
P < 0.001
<0.001
–
<0.001
<0.001
<0.001
<0.001
Block Design 40.47 (17.00) 44.87 (15.08) 32.15 (14.52) 46.55 (14.17) 80.30 (3, 3098)
P < 0.001
<0.001
–
<0.05
<0.001
<0.001
NS
DFAR neutral 77.76 (17.75) 80.43 (15.03) 76.18 (16.95) 81.14 (15.17) 10.44 (3, 2981)
P < 0.001
<0.05
–
NS
NS
<0.05
NS
DFAR happy 86.48 (13.07) 88.20 (10.72) 82.59 (13.66) 87.33 (11.12) 5.51 (3, 2981)
NS
–
–
–
–
–
–
DFAR fearful 47.23 (19.80) 52.54 (19.63) 48.35 (18.98) 53.75 (18.22) 23.39 (3, 2981)
P < 0.001
<0.001
–
NS
<0.001
NS
<0.001
DFAR angry 62.12 (20.88) 68.81 (19.22) 60.61 (20.46) 70.43 (18.60) 30.06 (3, 2981)
P < 0.001
<0.001
–
NS
<0.001
<0.001
NS
DFAR total 68.40 (10.77) 72.50 (9.35) 66.93 (10.45) 73.16 (9.13) 40.78 (3, 2981)
P < 0.001
<0.001
–
NS
<0.001
<0.001
NS
BFRT 22.76 (2.31) 23.17 (2.16) 22.44 (2.44) 23.14 (2.05) 5.73 (3, 3178)
NS
–
–
–
–
–
–
Hinting Task 17.54 (2.78) 18.84 (1.66) 18.79 (1.62) 19.08 (1.31) 85.31 (3, 3101)
P < 0.001
<0.001
–
NS
<0.001
<0.05
<0.001
WLT, word learning test; RST, response shifting task; CPT, continuous performance test; DFAR, degraded facial affect recognition; BFRT, Benton facial recognition test.
*P-values after Bonferroni correction.
For WLT Recognition more conservative results from non-parametric analyses are presented.
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71verbal learning and memory (15, 32–34). Impaired
performance on the Hinting Task in patients is in
accordance with meta-analytic results on theory of
mind performance in schizophrenia (35).
Although the neurocognitive pattern in patients
is fairly robust across studies, the magnitude of
impairment is still under discussion. In the present
study, the eﬀect sizes for patients ranged from
)0.18 to )1.34 SD, with an average cognitive
alteration of )0.61 SD ()0.70 for neurocognition
and )0.45 for social cognition). This is mild
compared with the approximate average cognitive
deﬁcit of )1 SD suggested by previous research
in schizophrenia patients (32). One factor that
may have contributed to these conservative ﬁnd-
ings is that setting an extreme of three SD below
the mean may have artiﬁcially truncated the true
range of some cognitive tasks. Another possibility
is that the higher percentage of missing data in
the patient group may have selected out those
who were too impaired to complete cognitive
testing. Alternatively, the inclusion of tests that
have been previously associated with premorbid
intellectual functioning and education (Informa-
tion, Arithmetic) into a composite score may have
produced a measure that is not optimally repre-
sentative of current neurocognitive impairment
(20). Moreover, even though the majority of
patients were diagnosed with schizophrenia-related
disorders, the decision to include patients with
other non-aﬀective psychotic disorders may have
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Fig. 1. Age- and gender-corrected z-scores for patients, siblings, parents, and controls. WLT, word learning task; Immed, immediate
recall; Retent, retention rate; RST, response shifting task; RST RT, reaction time cost; RST Acc, accuracy cost; CPT, continuous
performance test; CPT RT, CPT reaction time; CPT Acc, CPT accuracy; Digit symb, Digit Symbol-coding; Inform, information;
Arithm, arithmetic; Block Des, block design; DFAR, degraded facial aﬀect recognition; Neutr, neutral; BFRT, Benton facial
recognition test; Hint, Hinting Task.
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scores for alteration are £)1 SD (a) and £)2 SD (b) from the
control mean.
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72attenuated eﬀect sizes. However, diﬀerentiating
between non-aﬀective psychotic disorders is some-
times diﬃcult, and focusing exclusively on the
inclusion of schizophrenia patients may inﬂate
eﬀect sizes through selection bias. Despite the fact
that cognitive dysfunction is not a DSM criterion
for schizophrenia, psychotic patients who are
cognitively intact may be more likely to be diag-
nosed with, for example, psychotic disorder not
otherwise speciﬁed or substance-induced psychosis.
Finally, it cannot be excluded that the prerequisite
for patients to have family members who were able
and willing to participate in the study may have
selected out the more socially isolated and
impaired patients.
The recognition of happy aﬀect is known to be
relatively preserved in patients with psychotic
disorder (36), which was also illustrated by our
results. The absence of signiﬁcant alterations in
RST conﬂict reaction time should be interpreted in
combination with alterations in RST conﬂict
accuracy. Results suggest that patients have more
problems modifying their behavior in response to
negative feedback because they do not adapt
adequately to the reversal condition by taking
relatively more time. This could be explained by
diminished cognitive ﬂexibility in schizophrenia,
conceptualized as the ability to coordinate atten-
tion and response to two or more ongoing tasks
and to adaptively switch response strategies in
accord with contextual demands (37).
Results in siblings and parents indicate that
alterations in the domains of verbal learning,
processing speed, reasoning and problem solving,
working memory, and acquired knowledge are
promising cognitive intermediate phenotypes for
schizophrenia, which is supported by the literature
(5, 8). Eﬀect sizes for these domains were mild to
moderate, and between-group comparisons with
control subjects survived Bonferroni correction.
The average eﬀect size in siblings was, however,
relatively low ()0.18 SD, range )0.01 to )0.43 SD)
compared with the literature. Meta-analyses in
unaﬀected relatives have reported eﬀect sizes of
)0.37 (range )0.28 to )0.54) and )0.41
(SD = 0.38) (5, 6), which is more in line with the
average eﬀect size of )0.34 (range +0.13 to )1.17)
found in the present parent sample.
Three cognitive domains – namely atten-
tion ⁄vigilance, set-shifting ability, and social cog-
nition – did not show signiﬁcant alteration in both
genetic high-risk groups. Although several studies
have reported that siblings perform worse on
diﬀerent versions of the CPT, including the
CPT-AX (5, 6, 38), the present study did not
ﬁnd signiﬁcant diﬀerences in siblings and parents.
It may be that the CPT used in the present study
did not suﬃciently burden early aspects of stim-
ulus encoding and perceptual analysis, resulting in
a processing load that was too low to be sensitive
in relatives (38, 39). Studies investigating set-
shifting ability in healthy relatives of patients have
yielded mixed results with smaller eﬀect sizes than
for various other cognitive functions (5, 6).
Furthermore, recent studies suggest that set-shift-
ing ability may not aggregate in families and
therefore may not be a robust intermediate
phenotype (40). The present study supports these
ﬁndings and furthermore suggests that set-shifting
ability may show only relatively mild alterations in
patients ()0.31 SD), in contrast to the large,
clinically relevant eﬀect sizes reported previously
(32, 33).
While the social cognitive tasks yielded signif-
icant performance alterations in parents, diﬀer-
ences between siblings and control subjects for
DFAR total (P < 0.02), DFAR fearful
(P < 0.03), DFAR angry (P < 0.02), and Hint-
ing Task (P < 0.04) did not survive Bonferroni
correction. Worse performance in parents com-
pared with siblings was unexpected because the
parent group has passed the main age period of
risk of developing a psychotic disorder (41). It is
possible that the sibling group may have been
relatively healthy, as perhaps they share fewer risk
genes with their aﬀected relatives than the parent
group. Alternatively, age diﬀerences between the
parent group and the oldest control group may
have inﬂated the eﬀect sizes in parents. Post hoc
analyses in the control group did not, however,
show an eﬀect of age on the Hinting Task
(B = 0.00005, P = 0.99) or the DFAR angry
faces (B = )0.09, P = 0.23). Worse theory of
mind performance in parents of schizophrenia
patients compared with healthy control parents
has been reported before (42). Compromised
social cognitive functioning in parents but not
in siblings supports prior evidence that mentaliz-
ing impairment in schizophrenia may reﬂect gen-
eral cognitive deﬁcits or residual symptom
expression, rather than represent a speciﬁc trait
marker (43, 44). Previous research has suggested
that neurocognition and social cognition are
distinct, yet correlated domains in psychosis (45,
46). Social cognition may serve as a mediator
between neurocognition and community function-
ing in patients with psychotic disorder, acting
sequentially on the same pathway (45–48). It can
therefore be speculated that siblings with neuro-
cognitive alterations in the absence of social
cognitive alterations may display no reduction in
community functioning, whereas parents who
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73display both neurocognitive and social cognitive
alterations may show diminished community
functioning. The validity of this hypothesis
should be tested in future studies.
Although comparing mean performance in indi-
vidual cognitive domains between patients, rela-
tives, and controls provides indispensable
information about putative intermediate pheno-
types (Fig. 1), it does not show how cognitive
alterations are distributed over the subject groups.
For example, a mild alteration on a cognitive
subtest in siblings could be caused by a majority of
siblings displaying mild alterations or by a severe
alteration in only a small subgroup. For this
reason, total impairment scores were calculated
for each of the subject groups. Figure 2a shows
that with the cut-oﬀ £)1 SD from the control
mean, fairly equal proportions of patients demon-
strated no, mild, moderate, or severe impairments,
which corresponds with the concept of a contin-
uum of neurocognitive functioning in patients with
schizophrenia (29). The proportion of patients with
a neurocognitive proﬁle within the normal range is
similar to the 15–30% that was reported in a recent
review (10). Moving the cut-oﬀ from £)1S Dt o
£)2 SD (Fig. 2b) increases dramatically the rate of
patients without cognitive impairment, emphasiz-
ing the relevance of using more than one criterion
for cognitive impairment (49).
The proportions of mild, moderate, and severe
cognitive impairment in siblings and parents are
intermediate between patients and control subjects,
which may represent a dose–response association
for genetic load. With the £)1 SD cut-oﬀ, approx-
imately 50% of the relatives display no alterations
against 70% of the control subjects. In a study by
Egan et al. (49), the proportions of subjects with-
out cognitive impairments (£)1 SD) were higher:
62–75% in siblings against 77–91% in control
subjects. Using £)2 SD as a cut-oﬀ, these rates rise
substantially to around 90% in the relatives. This
indicates that with a more conservative criterion of
alteration, parents and siblings move away from
their aﬀected relatives to become almost indistin-
guishable from control subjects.
The relatively small eﬀect sizes are especially
noteworthy given that education or IQ was not
pursued as a covariate. It may be argued that not
controlling for these potential confounders may
have inﬂated eﬀect sizes. However, psychotic
disorders are neurodevelopmental in nature, and
subtle deﬁcits on neurocognitive measures during
childhood and adolescence have been associated
with an increased risk of non-aﬀective psychosis
(50). Controlling for education or IQ would thus
be inappropriate, given that they are powerfully
aﬀected by psychosis (26) and genetic vulnerability
for psychosis (51). Adjusting for education or IQ
would successfully remove, but not control for
the variance because of education and IQ, which
are meaningful components of the psychotic dis-
order phenotype (52). The present study therefore
pursued parental education as covariate in the
analyses instead (52).
Some limitations should be taken into consider-
ation when interpreting the results. Not all subjects
had complete cognitive test scores. This was
predominantly because of problems related to
computerized assessment and data storage, which
form a challenge in multi-centre studies (53).
However, patient status also aﬀected the number
of missing test results. Therefore, it cannot be
excluded that patients with more cognitive altera-
tions were more likely to have missing data,
resulting in attenuated eﬀect sizes. Second, the
issue that control subjects are often matched to the
patient group, resulting in control groups of
younger age than the parent or mixed relative
group, is a common concern in this ﬁeld of
research (6). In a meta-analysis on cognitive
functioning in unaﬀected relatives, an overall
Cohens d of 0.36 was reported for studies with
age-matched groups vs. d = 0.48 for those with
non-age-matched groups (6). Covarying for age,
although appealing, is an inappropriate way of
dealing with group diﬀerences, because it repre-
sents a deﬁning group characteristic of the parent
sample (52). Therefore, age- and gender-corrected
z-scores were calculated in this study to account for
age diﬀerences. Although this resulted in the best
possible ﬁt, optimal age correction could not be
achieved, as parents in the oldest age group had a
mean age of 54 against a mean age of 46 in the
oldest control group. Higher mean age in parents
would most likely inﬂate performance diﬀerences
in speeded tasks such as Digit Symbol-coding and
CPT. Instead, the tasks that showed more altera-
tions in parents compared with siblings were
unspeeded tasks assessing social cognition,
making a confounding eﬀect of age less likely.
In conclusion, this study suggests that famil-
ial predisposition to psychotic disorder is associ-
ated with immediate verbal learning, processing
speed, reasoning and problem solving, acquired
knowledge, and working memory, with modest
eﬀect sizes. Tasks assessing set-shifting ability and
vigilance with low processing load did not diﬀer-
entiate relatives from controls. While half of the
unaﬀected relatives may experience some degree of
clinically relevant cognitive impairment, severe
cognitive impairments seem to be restricted to a
minority.
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